Eisai Commences Business Activities at New Pharma Sales Subsidiary in Israel

TOKYO, Jan 19, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that fully-fledged operations and business activities have begun at Eisai Israel Ltd., a pharmaceutical sales subsidiary recently established in Tel Aviv in the State of Israel (Israel). Eisai Israel is a wholly-owned subsidiary of Eisai’s European regional headquarters, Eisai Europe […]

Eisai Listed as a Global 100 Most Sustainable Corporation for The Seventh Time Highest Ranked Global Pharmaceutical Company

TOKYO, Jan 19, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced that it has been listed in the 2023 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corporate Knights, Inc. This marks Eisai’s seventh inclusion on the list. Ranked 53rd, […]

CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again

HONG KONG, Nov 14, 2022 – (ACN Newswire via SEAPRWire.com) – China Resources Pharmaceutical Group Limited (“CR Pharmaceutical” or the “Group”) (stock code: 3320) has announced that the Group will once again be included as a constituent stock of the MSCI China Index, which will become effective after the market close on 30 November 2022. […]

Pharmaron: A Premier R&D Services Provider for the Life Sciences Industry, Dedicated to Innovation and Reform

HONG KONG, Dec 17, 2021 – (ACN Newswire via SEAPRWire.com) – 2021 the 11th Hong Kong International Finance Forum & China Securities Golden Bauhinia Awards Ceremony, themed “The 14th Five-Year, a New Journey”, was held at Hong Kong Convention and Exhibition Center dated December 17, 2021. Around 200 financial officials and senior officers in securities […]

NEC: Technology Leaders Partner to Conduct Groundbreaking Drone Tests in Japan

TOKYO, Nov 8, 2021 – (JCN Newswire via SEAPRWire.com) – Several leading Japanese technology firms, including BIRD INITIATIVE, Inc. (hereinafter “BIRD INITIATIVE”)(1), ANA HOLDINGS INC. (hereinafter “ANAHD”)(2), AIN HOLDINGS INC. (hereinafter “AIN HD”)(3), and NEC Corporation (hereinafter “NEC”),(4) have partnered with the Hokkaido Bureau of Economy, Trade and Industry (hereinafter “METI”)(5) to conduct a drone […]

Viva Biotech Announced 2020 Annual Results

HONG KONG, Mar 31, 2021 – (ACN Newswire via SEAPRWire.com) – Viva Biotech Holdings (1873.HK) announced that during the year ended December 31, 2020 (the “Reporting Period”), revenue of the Group increased significantly to RMB 697.0 million from RMB 323.1 million for the corresponding period last year, representing a YoY increase of 115.7%; gross profit […]

Hepalink Announces 2020 Interim Results

HONG KONG, Aug 31, 2020 – (ACN Newswire) – Shenzhen Hepalink Pharmaceutical Co., Ltd. (Stock Code: 9989.HK; “Hepalink” or the “Group”) today announced the unaudited consolidated results for the first half year of 2020 (“1H2020”) ended June 30, 2020 (the “Reporting Period”). Financial HighlightsFor the six months ended 30 June 2020, the Group recorded:– Total […]

Sihuan Pharmaceutical Launched an Equity Incentive Plan to Inject New Impetus for the Company’s Growth

HONG KONG, Aug 27, 2020 – (ACN Newswire) – Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 “Sihuan Pharmaceutical” or the “Company”, together with its subsidiaries, the “Group”) announced that on 26 August 2020, the Company granted a total of 94,656,000 share options (the “Share Options”) to the eligible participants of the Company (the “Grantees”) to […]

Sihuan Pharmaceutical Announces 2020 Interim Results

HONG KONG, Aug 25, 2020 – (ACN Newswire) – Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 “Sihuan Pharmaceutical” or the “Company”, together with its subsidiaries, the “Group”) is pleased to announce its interim results for the 6 months ended 30 June 2020 (the “Period”). Financial Summary Under the influence of pharmaceutical policies and COVID-19 during […]